Shares of Corbus Pharmaceuticals Holdings Inc. /zigman2/quotes/201549545/lastsale CRBP +6.04% advanced 4.76% to $0.44 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.31% rising 3.41% to 14,239.88 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.41% rising 1.17% to 35,131.86. This was the stock's second consecutive day of gains. Corbus Pharmaceuticals Holdings Inc. closed $3.56 short of its 52-week high ($4.00), which the company reached on February 11th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Fate Therapeutics Inc. /zigman2/quotes/209623007/composite FATE +3.06% rose 13.32% to $41.51, Vanda Pharmaceuticals Inc. /zigman2/quotes/200957783/composite VNDA +1.96% rose 2.85% to $15.16, and Viking Therapeutics Inc. /zigman2/quotes/204618964/composite VKTX -4.12% rose 3.63% to $3.71. Trading volume (1.2 M) eclipsed its 50-day average volume of 989,779.